Achilles Therapeutics (ACHL)
(Delayed Data from NSDQ)
$0.78 USD
-0.02 (-2.14%)
Updated Apr 19, 2024 03:59 PM ET
After-Market: $0.78 0.00 (-0.37%) 7:00 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.46 |
EPS Last Quarter | -0.46 |
Last EPS Surprise | NA |
ABR | 2.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.34 |
Next Year | -1.33 |
EPS (TTM) | -1.74 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.46 | -0.48 | -1.34 | -1.33 |
# of Estimates | 2 | 1 | 3 | 3 |
Most Recent Consensus | NA | NA | -1.82 | -1.74 |
High Estimate | -0.43 | -0.48 | -0.27 | -0.16 |
Low Estimate | -0.49 | -0.48 | -1.93 | -2.08 |
Year ago EPS | -0.44 | -0.42 | -1.74 | -1.34 |
Year over Year Growth Est. | -4.55% | -14.29% | 22.99% | 0.99% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 2 | 0 |
Down Last 60 Days | 0 | 0 | 2 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.46 | -0.48 | -1.34 | -1.33 |
7 Days Ago | -0.46 | -0.48 | -1.34 | -1.33 |
30 Days Ago | -0.56 | -0.57 | -1.36 | -2.93 |
60 Days Ago | -0.56 | -0.57 | -1.36 | -2.93 |
90 Days Ago | -0.56 | -0.57 | -1.36 | -2.93 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.46 | -0.48 | -1.34 | -1.33 |
Zacks Consensus Estimate | -0.46 | -0.48 | -1.34 | -1.33 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.46 | -0.42 | -0.42 | -0.44 | NA |
Estimate | NA | -0.38 | -0.40 | -0.41 | NA |
Difference | NA | -0.04 | -0.02 | -0.03 | -0.03 |
Surprise | NA | -10.53% | -5.00% | -7.32% | -7.62% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more